← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2005Last known activity
Oct 27, 2021
Timeline
1990s
- Jun 1, 1996
GWT-TUD GmbH— Founded
Drugs by trial phase (53 distinct, 28 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Adenocarcinoma
- Aggression
- Anemia, Iron-Deficiency
- Cardiovascular Diseases
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Dyslipidemias
- Edema
- Hemophilia A
- Hypoglycemia
- Inflammation
- Ischemia
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Macular Edema
- Metabolic Syndrome
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms, Plasma Cell
- Neurodermatitis
- Pancreatic Neoplasms
- Preleukemia
- Sarcoma
- Sepsis
- Stomach Neoplasms
- Syndrome
- Thrombosis
- Venous Thrombosis
Recent trials (31)
- NCT05181592Lead sponsorPhase 3Oct 27, 2021
- NCT04833114Lead sponsorPhase 3Apr 30, 2021
- NCT04188639Lead sponsorPhase 2May 31, 2020
- NCT04257448Lead sponsorPhase 1/Phase 2Mar 31, 2020
- NCT04062656CollaboratorPhase 2Sep 1, 2019
- NCT04061239Lead sponsorPhase 2Aug 19, 2019
- NCT04121507Lead sponsorPhase 2Jun 24, 2019
- NCT03824080Lead sponsorPhase 2Dec 20, 2018
- NCT03807479Lead sponsorPhase 2Dec 11, 2018
- NCT03735758Lead sponsorPhase 4Nov 2, 2018
- NCT03731832Lead sponsorPhase 2Sep 20, 2018
- NCT03568136Lead sponsorPhase 2Jun 30, 2018
- NCT03423355Lead sponsorPhase 4May 1, 2018
- NCT03437330Lead sponsorPhase 4Mar 1, 2018
- NCT02992860Lead sponsorPhase 2Jul 1, 2016
Details
- Founded
- Dresden, DE Jun 1, 1996
- Last known activity
- Oct 27, 2021
Notes
CRO